XK and influenza: Currently licensed influenza vaccines induce subtype-specific virus-neutralizing antibodies with specificity for the densely expressed surface antigens neuraminidase (NA) and hemagglutinin (HA), of which eighteen HA subtypes and eleven NA subtypes have been identified.